Uveal melanoma: updated considerations on current management modalities

Area of Science:

• Ophthalmology
• Oncology
• Pathology

Background:

• Uveal melanoma growth rates and treatment effects are critical for patient outcomes.
• Tumor size significantly influences metastasis risk, with dissemination beginning after 7 mm diameter.

Purpose of the Study:

• To analyze the relationship between uveal melanoma size, growth rate, and metastasis.
• To evaluate the impact of treatment modalities on survival and patient well-being.
• To determine optimal management strategies based on tumor characteristics and patient factors.

Main Methods:

• Review of published data on uveal melanoma growth rates.
• Estimation of tumor doubling times to assess metastatic risk.
• Histopathological analysis of irradiated melanomas.
• Comparison of outcomes for enucleation versus conservative management.

Main Results:

• Metastasis risk increases incrementally with tumor size from 7 to 10 mm, reaching approximately 16%.
• Pre-therapeutic dissemination is the primary cause of early metastatic death, limiting the assessment of therapy impact on survival.
• Irradiated melanomas show persistent reproductive activity, and enucleation may offer better psychological well-being for patients with a functional fellow eye.

Conclusions:

• Conservative management is suitable for small melanomas, patients with limited life expectancy, those with a single functioning eye, or those refusing enucleation.
• Early tumor detection and size assessment are crucial for predicting metastasis risk in uveal melanoma.
• Treatment decisions should consider tumor characteristics, metastasis risk, and patient quality of life.